Sep 2, 2019   SOURCE: PR NewsWire

US Post-Traumatic Stress Disorder Market Report 2019: Treatments, Pipeline, Epidemiology, Marketed Drugs, Size, Sales, Competitive Landscape 2014-2024

DUBLIN, Sept. 2, 2019 /PRNewswire/ -- The "US Post-Traumatic Stress Disorder Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The latest research, US Post-Traumatic Stress Disorder Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Post-Traumatic Stress Disorder pipeline products, Post-Traumatic Stress Disorder epidemiology, Post-Traumatic Stress Disorder market valuations and forecast, Post-Traumatic Stress Disorder drugs sales and competitive landscape in the US.

The research is classified into seven sections- Post-Traumatic Stress Disorder treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

    --  Post-Traumatic Stress Disorder pipeline: Find out the products in
        clinical trials for the treatment of Post-Traumatic Stress Disorder by
        development phase 3, phase 2, and phase 1, by pharmacological class and
        companies developing the products
    --  Post-Traumatic Stress Disorder epidemiology: Find out the number of
        patients diagnosed (prevalence) with Post-Traumatic Stress Disorder in
        the US
    --  Post-Traumatic Stress Disorder drugs: Identify key products marketed and
        prescribed for Post-Traumatic Stress Disorder in the US, including trade
        name, molecule name, and company
    --  Post-Traumatic Stress Disorder drugs sales: Find out the sales revenues
        of Post-Traumatic Stress Disorder drugs in the US
    --  Post-Traumatic Stress Disorder market valuations: Find out the market
        size for Post-Traumatic Stress Disorder drugs in 2018 in the US. Find
        out how the market advanced from 2014 and forecast to 2024
    --  Post-Traumatic Stress Disorder drugs market share: Find out the market
        shares for key Post-Traumatic Stress Disorder drugs in the US

Benefits of this Research:

    --  Support monitoring and reporting national Post-Traumatic Stress Disorder
        market analysis and sales trends
    --  Track competitor drugs sales and market share in the US Post-Traumatic
        Stress Disorder market
    --  Track competitive developments in Post-Traumatic Stress Disorder market
        and present key issues and learnings
    --  Synthesize insights for Post-Traumatic Stress Disorder market and
        products to drive business performance
    --  Answer key business questions about the Post-Traumatic Stress Disorder
        market
    --  Evaluate commercial market opportunity assessment, positioning, and
        segmentation for Post-Traumatic Stress Disorder products
    --  Supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1 Post-Traumatic Stress Disorder Treatments

2 Post-Traumatic Stress Disorder Pipeline

3 US Post-Traumatic Stress Disorder Epidemiology

4 Marketed Drugs for Post-Traumatic Stress Disorder in US

5 US Post-Traumatic Stress Disorder Market Size and Forecast

6 US Post-Traumatic Stress Disorder Products Sales and Forecast

7 US Post-Traumatic Stress Disorder Market Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/u4bv84

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/us-post-traumatic-stress-disorder-market-report-2019-treatments-pipeline-epidemiology-marketed-drugs-size-sales-competitive-landscape-2014-2024-300910276.html

SOURCE Research and Markets